Innovative practices of ventilatory support with pediatric patients

Pediatric Critical Care Medicine

Volumn 4, Issue 1, 2003, Pages 8-20

  Marraro, Giuseppe A ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Hemofiltration; Plasma filtration; Sepsis

Indexed keywords

FLUOROCARBON; LUNG SURFACTANT; NITRIC OXIDE;

ARTIFICIAL VENTILATION; BAROTRAUMA; BODY POSTURE; HUMAN; HYPERCAPNIA; INJURY; LUNG; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG VENTILATION; METHODOLOGY; PEDIATRICS; PHYSIOLOGY; REVIEW;

BAROTRAUMA; FLUOROCARBONS; HUMANS; HYPERCAPNIA; LUNG; LUNG COMPLIANCE; NITRIC OXIDE; PEDIATRICS; POSTURE; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; PULMONARY VENTILATION; RESPIRATION, ARTIFICIAL;

EID: 85047687280     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/00130478-200301000-00003     Document Type: Article

References (184)

1. Rotta AT, Gunnarsson B, Fuhrman BP, et al: Comparison of lung protective ventilation strategies in a rabbit model of acute lung injury. Crit Care Med 2001; 29: 2176-2184
2. Amato MB, Barbas CS, Medeiros DM: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354
3. Brochard L, Roudot-Thoraval E, et al: Tidal volume reduction for prevention of ventilator- induced lung injury in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158:1831-1838
4. Chambers HM, van Velzen D: Ventilatorrelated pathology in the extremely immature lung. Pathology 1989; 21:79-83
5. International Consensus Conference in Intensive Care Medicine: Ventilator-associated lung injury in ARDS. Intensive Care Med 1999; 25:1444-1452
6. Dreyfuss D, Saumon G: Barotrauma is volutrauma, but which volume is the one responsible? Intensive Care Med 1992; 18: 139-141
7. Nilsson R, Grossmann G, Robertson B: Pathogenesis of neonatal lung lesions induced by artificial ventilation: Evidence against the role of barotrauma. Respiration 1980; 40:218-225
8. Holm BA, Matalon S, Finkelstein JH, et al: Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988; 65:2672-2678
9. Dreyfuss D, Saumon G: Role of tidal volume, FRC and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis 1993; 148:1194-1203
10. Gammon RB, Shin MS, Groves RH, et al: Clinical risk factors by pulmonary barotrauma: A multivariate analysis. Am J Respir Crit Care Med 1995; 152:1235-1240
11. Ranieri VM, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999 282:54-61
12. Tremblay LN, Valenza R, Ribeiro SP, et al: Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952
13. Saugstad OD: Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease. Acta Paediatr 1996; 85:1-4
14. Dreyfuss D, Saumon G: Ventilator-induced lung injury: Lessons from experimental studies [state of the art]. Am J Respir Crit Care Med 1998; 157:294-330
15. Bone RC, Francis PB, Pierce AK: Pulmonary barotrauma complicating positive endexpiratory pressure. Abstr. Am Rev Respir Dis 1973; 111:921
16. Hickling KG: Ventilatory management of ARDS: Can it affect the outcome? Intensive Care Med 1990; 16:219-226
17. Lee PC, Helsmoortel CM, Cohn SM, et al: Are low tidal volumes safe? Chest 1990; 97:425-429
18. Kiiski R, Takala J, Fari A, et al: Effect of tidal volume on gas exchange and oxygen transport in the adult respiratory distress syn drome. Am Rev Respir Dis 1992; 146: 1131-1135
19. Dreyfuss D, Soler P, Basset G, et al: High inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume, and positive endexpiratory pressure. Am Rev Respir Dis 1988; 137:1159-1164
20. Williams TJ, Tuxen DV, Scheinkestel CD, et al: Risk factor for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992; 146: 607-615
21. Tuxen DV, Lane S: The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987; 136:872-879
22. Mergoni M, Martelli A, Volpi A, et al: Impact of positive end-expiratory pressure on chest wall and lung pressure volume curve in acute respiratory failure. Am J Respir Crit Care Med 1997; 156:846-854
23. Rimensberger PC, Pache JC, McKerlie C, et al: Lung recruitment and lung volume maintenance: A strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation. Intensive Care Med 2000; 26:745-755
24. Matthews BD, Noviski N: Management of oxygenation in pediatric acute hypoxemic respiratory failure. Pediatr Pulmonol 2001; 32:459-470
25. Bateman ST, Arnold JH: Acute respiratory failure in children. Curr Opin Pediatr 2000; 12:233-237
26. Hernandez LA, Coker PJ, May S, et al: Mechanical ventilation increases microvascular permeability in oleic acid injured lungs. J Appl Physiol 1990; 69:2057-2061
27. Lachmann B: Open the lung and keep the lung open. Intensive Care Med 1992; 18: 319-321
28. Meredith KS, deLemos RA, Coalson JJ, et al: Role of the lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 1989; 66: 2150-2158
29. Slutsky AS: Lung injury caused by mechanical ventilation. Chest 1999; 116(Suppl): 9S-15S
30. Clark RH, Slutsky AS, Gerstmann DR: Lung protective strategy of ventilation in the neonate: What are they? Pediatrics 2000; 105: 112-114
31. Marraro G, Mannucci F, Galbiati AM, et al: The advantages of a new mode of artificial ventilation: Pressure regulated volume controlled (PRVC) ventilation. Ped Res 1994; 35(4 Suppl):344A, 2047
32. Marraro G, Casiraghi G, Galbiati AM: A study of pressure regulated volume control ventilation in natural surfactant treated infants with RDS. Ped Res 1995; 4(Suppl): 223A, 1321
33. Esteban A, Frutos F, Tobin MJ, et al: A comparison of four methods of weaning from mechanical ventilation. N Engl J Med 1995; 332:345-350
34. Hazelzet JA, Petru R, Ouden CD, et al: New modes of mechanical ventilation for severe respiratory failure. Crit Care Med 1993; 21(9 Suppl):S366-S367
35. Kocis KC, Dekeon MK, Rosen HK, et al: Pressure-regulated volume control vs volume control ventilation in infants after surgery for congenital heart disease. Pediatr Cardiol 2001; 22:233-237
36. McIntyre NR, Gropper C, Westfall T: Combining pressure-limiting and volumecycling features in a patient-interactive breath. Crit Care Med 1994; 22:353-357
37. Markstrom A, Hedlund A, Lichtwarck- Aschoff M, et al: Impact of different inspiratory flow patterns on arterial CO2-tension. Ups J Med Sci 2000; 105:17-29
38. Polese G, Lubli P, Poggi R, et al: Effects of inspiratory flow waveforms on arterial blood gases and respiratory mechanics after open heart surgery. Eur Respir J 1997; 10: 2820-2824
39. Burns SM: Understanding, applying, and evaluating pressure modes of ventilation. AACN Clin Issues 1996; 7:495-506
40. Markstrom AM, Lichtwarck-Aschoff M, Svensson BA, et al: Ventilation with constant versus decelerating inspiratory flow in experimentally induced acute respiratory failure. Anesthesiology 1996; 84:882-889
41. Arnold J, Truog R, Thompson J, et al: High frequency oscillatory ventilation in pediatric respiratory failure. Crit Care Med 1993; 21:272-278
42. Arnold JH: High frequency oscillatory ventilation: Theory and practice in paediatric patients. Paediatr Anaesth 1996; 6:437-441
43. Carlo W, Siner B, Chatburn RE, et al: Early randomized intervention with high-frequency jet ventilation in respiratory distress syndrome. J Pediatr 1990; 117:765-770
44. Keszler M, Donn SM, Bucciarelli RE, et al: Multicenter controlled trial comparing high-frequency jet ventilation and conventional mechanical ventilation in newborn infants with pulmonary interstitial emphysema. J Pediatr 1991; 119:85-93
45. Smith BE: High frequency ventilation: Past, present and future? BJA 1990; 65:130-138
46. Kinsella JP, Clark RH: High-frequency oscillatory ventilation in paediatric critical care. Crit Care Med 1993; 21:174-175
47. Beamer WC, Prough DS, Royster RL, et al: High frequency jet ventilation produces auto- PEEP. Crit Care Med 1984; 12:734-735
48. Clark RH, Wiswell TE, Null DM, et al: Tracheal and bronchial injury in high-frequency oscillatory ventilation compared with conventional positive pressure ventilation. J Pediatr 1987; 111:114-118
49. Ogawa Y, Miyasaka K, Kawano T, et al: A multicenter randomized trial of highfrequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Hum Dev 1993; 32:1-10
50. HIFO Study Group: Randomized study at high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 1993; 122:609-619
51. Arnold JH, Hanson JH, Toro-Figuero LO, et al: Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994; 22:1530-1539
52. Medbo S, Finne PH, Hansen TW: Respiratory syncytial virus pneumonia ventilated with high-frequency oscillatory ventilation. Acta Paediatr 1997; 86:766-768
53. Duval EL, Leroy PL, Gemke RJ, et al: Highfrequency oscillatory ventilation in RSV bronchiolitis patients. Respir Med 1999; 93: 435-440
54. Mammel MC, Ophoven JP, Lewallen PK, et al: Acute airway injury during highfrequency jet ventilation and high-frequency oscillatory ventilation. Crit Care Med 1991; 19:394-398
55. Man GCW, Ahmed IH, Logus JW, et al: High-frequency oscillatory ventilation increases canine pulmonary epithelial permeability. J Appl Physiol 1987; 63:1871-1876
56. The HIFI Study Group: High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 1989; 320:88-93
57. Clark R, Dukes F, Bachman T, et al: Intraventricular hemorrhage and high frequency ventilation: A meta-analysis of prospective clinical trials. Pediatrics 1996; 98: 1058-1061
58. Butha T, Clark RH, Henderson-Smart DJ: HFOV vs conventional ventilation. Cochrane Review, The Cochrane Library, 2001, Issue 2
59. Krishnan JA, Brower RG: High-frequency ventilation for acute lung injury and ARDS. Chest 2000; 118:795-807
60. Marraro G: Synchronized independent lung ventilation in pediatric age. ACP Appl Cardiopulm Pathophys 1987; 2:283-288
61. Marraro G: Simultaneous independent lung ventilation in pediatric patients. Crit Care Clin 1992; 8:131-145
62. Marraro G: Selective endobronchial intubation in paediatrics: the Marraro paediatric bilumen tube. Paediatr Anaesth 1994; 4:255-258
63. Turner MWH, Buchanan CCR, Brown SW: Paediatric one lung ventilation in the prone position. Paediatr Anaesth 1997; 7:427-429
64. Hammer GB, Engel TP: Single lung ventilation in children. http://gasnet.med.yale.edu/slvc/index.php
65. Marraro G: New modes of pulmonary ventilation. In: Advances in Paediatric Anaesthesia. Dalens B, Murat I, Bush G (Eds). Paris, ADARPEF, 1997, pp 57-88
66. East TP, Pace NL, Westenskow DR: Synchronous versus asynchronous differential lung ventilation with PEEP after unilateral acid aspiration in the dog. Crit Care Med 1983; 11:441
67. Frostell C, Hedenstierna G, Cronestrand R: Asynchronous ventilation in the dogs: Effects on lung blood flow and gas exchange. Clin Physiol 1995; 5(Suppl 3):59-64
68. Marraro G: Airway management. In: Principle and Practice of Pediatric Anesthesia. Bissonnete B, Dalens BJ (Eds). New York, McGraw-Hill, 2001, pp 778-814
69. Marraro G: Intraoperative ventilation in paediatrics. Paediatr Anaesth 1998; 8:372-382
70. Marraro GA, Luchetti M, Galassini EM, et al: Haemodynamic variations during independent lung ventilation in paediatrics. J Biocybernetics Biomedical Engineering 2002, In Press
71. Craig DB: Postoperative recovery of pulmonary function. Anesth Analg 1981; 60:46
72. Marraro G, Ottolenghi A, Galbiati AM: Laryngotracheoesophageal cleft: Role of synchronized independent lung ventilation. Ped Res 1993; 33:336A
73. Marraro G, Galassini EM, Padovani EM: Independent lung ventilation and exogenous surfactant in congenital diaphragmatic hernia complicated by unilateral lung pathology. Biol Neonate 1998; 74(Suppl 1):43-56
74. Nielsen JB, Sjostrand UH, Edgren EL, et al: An experimental study of different ventilatory modes in piglets in severe respiratory distress induced by surfactant depletion. Intensive Care Med 1991; 17:225-233
75. Tokioka H, Kinjo M, Hirakawa M: The effectiveness of pressure support ventilation for mechanical ventilatory support in children. Anesthesiology 1993; 78:880-884
76. Bonmarchand G, Chevron V, Chopin C, et al: Increased initial flow rate reduces inspiratory work of breathing during pressure support ventilation in patients with exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 1996; 22: 1147-1154
77. Brochard L, Harf A, Lorino H, et al: Inspiratory pressure support prevents diaphragmatic fatigue during weaning from mechanical ventilation. Am Rev Respir Dis 1989; 139:513-521
78. Kacmarek RM: The role of pressure support ventilation in reducing work of breathing. Respir Care 1988; 33:99-120
79. Gullberg N, Wimberg P, Sellde'n H: Pressure support ventilation increase cardiac output in neonates and infants. Paediatr Anaesth 1996; 6:311-315
80. Doctor A, Arnold J: Mechanical support of acute lung injury: Options for strategic ventilation. Crit Care Med 1999; 7:359-373
81. Hird MF, Greenough A: Patient triggered ventilation in chronically ventilator-dependent infants. Eur J Pediatr 1991; 150: 732-734
82. Sjostrand UH, Lichtwarck-Aschoff M, Nielsen JB, et al: Different ventilatory approaches to keep the lung open. Intensive Care Med 1995; 21:310-318
83. Mancebo J, Amaro P, Mollo JL, et al: Comparison of the effects of pressure support ventilation delivered by three different ventilators during weaning from mechanical ventilation. Intensive Care Med 1995; 21: 913-919
84. Mori N, Suzuki M: Trigger sensitivity of Servo 300 (Siemens Elema) for pressure support ventilation in an infant. Paediatr Anaesth 1994; 4:27-34
85. MacIntyre NR, Li-Ing H: Effects of initial flow rate and breath termination criteria on pressure support ventilation. Chest 1991; 99:134-138
86. Brower R, Shanholtz C, Fessler HE, et al: Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492-1498
87. Sheridan RL, Kacmarek RM, McEttrick MM, et al: Permissive hypercapnia as a ventilatory strategy in burned children: Effect on barotrauma, pneumonia, and mortality. J Trauma 1995; 39:854-859
88. Laffey JG, Ranaka M, Engelberts D, et al: Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000; 162:2287-2294
89. Shibata K, Cregg N, Engelberts D, et al: Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 1998; 158:1578-1584
90. Laffey JG, Engelberts D, Kavanagh BP: Injurious effects of hypocapnic alkalosis in the isolated lung. Am J Respir Crit Care Med 2000; 162:399-405
91. Ranieri VM, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999; 282:54-61
92. Slutsky AS, Tremblay LN: Multiple system organ failure: Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157:1721-1725
93. Ranieri VM, Suter PM, Slutsky AS: Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000; 284:43-44
94. Swallow CJ, Grinstein S, Sudsbury RA: Modulation of the macrophage respiratory burst by an acidic environment: The critical role of cytoplasmatic pH regulation by proton extrusion pumps. Surgery 1990; 108: 363-369
95. Zelikoff JT, Schlesinger RB: Modulation of pulmonary immune defense mechanisms by sulfuric acid: Effects on macrophagederived tumor necrosis factor and superoxide. Toxicology 1992; 76:271-281
96. Goldstein B, Shannon D, Todres D: Supercarbia in children: Clinical course and outcome. Crit Care Med 1990; 18:166-168
97. Hickling K, Joyce C: Permissive hypercapnia in ARDS and its effect on tissue oxygenation. Acta Anaesthesiol Scand 1995; 39: 201-208
98. Thorens J, Chopard P, Joillet J, et al: Effect of permissive hypercapnia on tissue oxygenation in acute respiratory failure. Am J Respir Crit Care Med 1994; 149:A68
99. Hickling KG: Lung protective ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 162:2021-2022
100. Woodgate PG, Davies MV: Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Review, Cochrane Database Syst Rev 2001; 2:CD002061
101. Feihl F, Perret C: Permissive hypercapnia: How permissive should we be? Am J Respir Crit Care Med 1994; 150:1722-1737
102. Tuxen D: Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150: 870-874
103. Sheridan RL, Kacmarek RM, McEttrick MM: Permissive hypercapnia as a ventilatory strategy in burned children: Effect on barotrauma, pneumonia, and mortality. J Trauma 1995; 39:854-859
104. Lamm W, Graham M, Albert R: Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 1994; 150:184-193
105. Mure M, Martling C, Lindahl S: Dramatic effect on oxygenation in patients with severe acute lung insufficiency treated in the prone position. Crit Care Med 1997; 25: 1539-1544
106. Pelosi P, Tubiolo D, Mascheroni D, et al: Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998; 157:387-393
107. Matthews BD, Noviski N: Management of oxygenation in pediatric acute hypoxemic respiratory failure. Pediatr Pulmonol 2001; 32:459-470
108. Kornecki A, Frndova H, Coates AL, et al: A randomized trial of prolonged prone positioning in children with acute respiratory failure. Chest 2001; 119:211-218
109. Curley MA, Thompson JE, Arnold JH: The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest 2000; 118:156-163
110. Numa AH, Hammer J, Newth CJ: Effect of prone and supine positions on functional residual capacity, oxygenation, and respiratory mechanics in ventilated infants and children. Am J Respir Crit Care Med 1997; 156(4 Pt 1):1185-1189
111. Shen XM, Zhoa W, Huang DS, et al: Effect of positioning on pulmonary function of newborns: Comparison of supine and prone position. Pediatr Pulmonol 1996; 21: 167-170
112. Enhorning G, Robertson B: Lung expansion in the premature rabbit fetus after tracheal desposition of surfactant. Pediatrics 1972; 50:58-66
113. Fujiwara T, Maeta H, Chida S, et al: Artifi- cial surfactant therapy in hyaline membrane disease. Lancet 1980; 1:55-59
114. MacIntyre NR, Coleman RE, Schuller FS, et al: Efficiency of the delivery of aerosolized surfactant to intubated patients with ARDS. Am Rev Resp Dis 1994; 149:A125
115. American Association for Respiratory Care: Aerosol consensus statement. Respir Care 1991; 36:916-921
116. Lewis JF, Ikegami M, Jobe AH, et al: Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993; 147:1364-1370
117. Walmrath D, Gunther A, Ghofrani HA, et al: Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996; 154:57-62
118. Nakamura CT, Ripka JF, McVeigh K, et al: Bronchoscopic instillation of surfactant in acute respiratory distress syndrome. Pediatr Pulmonol 2001; 31:317-320
119. Lam BCC: Surfactant lavage for the management of severe meconium aspiration syndrome. Biol Neonate 1999; 76(Suppl 1): 10-14
120. Lewis JF, Tabor B, Ikegami M, et al: Lung function and surfactant distribution in saline- lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 1993; 74: 1256-1264
121. Cochrane CG, Revak SD: Surfactant lavage treatment in a model of respiratory distress syndrome. Chest 1999; 116:85S-87S
122. Wiswell TE, Smith RM, Katz LB, et al: Bronchopulmonary segmental lavage with Surfaxin (KL4): Surfactant for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:1188-1195
123. Shapiro DL, Notter RH, Morin FC, et al: Double-blind, randomised trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 1985; 76:593
124. Hallman M, Merritt TA, Javernpaa AL, et al: Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial. J Pediatr 1985; 106:963
125. Raju TNK, Vidyasagar D, Bhat R, et al: Double- blind controlled trial of single dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1987; 1:651
126. Collaborative Europ Multicenter Study Group: Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 1988; 82:683
127. Bos AP, Tibboel D, Hazebroek FW, et al: Surfactant replacement in high-risk congenital diaphragmatic hernia. Lancet 1991; 338:1279
128. Valls i Soler A, Fernandez-Raunova B, Robertson B et al: Treatment of congenital diaphragmatic hernia with surfactant: A multicenter retrospective study. Biol Neonate 1998; 74(Suppl 1):54
129. Sherman MP, Campbell LA, Merritt TA, et al: Effects of different surfactants on pulmonary group B streptococcal infection in premature rabbits. J Pediatric 1994; 125: 939-947
130. Herting E, Gan XZ, Rauprich P, et al: Combined treatment with surfactant and specific immunoglobuliner reduces bacterial proliferation in experimental neonatal group B-streptococcal pneumonia. Am J Respr Crit Care Med 1999; 159:1862-1867
131. Herting E, Gefeller O, Land M, et al: Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000; 106:957-964
132. Slater AJ, Nichani SH, Macrae D, et al: Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukemia. Intensive Care Med 1995; 21:261-263
133. Creery WD, Hashmi A, Hutchison JS, et al: Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Pediatr Pulmonol 1997; 24:370-373
134. Westport CT: Surfactant protein A important in host defence against Pneumocystis carinii. J Infect Dis 2001; 183:943-952
135. Halliday HL, Speer CP, Robertson B, et al: Treatment of severe meconium aspiration syndrome with porcine surfactant. Eur J Pediatr 1996; 155:1047
136. Khammash H, Pearlman M, Wojtulewicz J, et al: Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92:135
137. Kinsella JP, Truog WE, Walsh WF, et al: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997; 131:55-62
138. Marraro G: Natural surfactant supplementation in ARDS in paediatric age. Minerva Anestesiol 1999; 65(Suppl 1):92
139. Taeusch HW: Treatment of acute (adult) respiratory distress syndrome. Biol Neonate 2000; 77(Suppl 1):2-8
140. Spragg RG: Surfactant therapy in acute respiratory distress syndrome. Biol Neonate 1998; 74(Suppl 1):15-20
141. Gregory TJ, Steinberg KP, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315
142. Luchetti M, Casiraghi G, Valsecchi R, et al: Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anesthesiol Scand 1998; 42:805
143. Luchetti M, Ferrero F, Gallini C, et al: Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002; 3:261-268
144. Tibby SM, Hatherill M, Wright SM, et al: Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000; 162:1251-1256
145. Willson DF, Jiao JH, Bauman LA, et al: Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996; 24:1281-1282
146. Willson DF, Zaritsky A, Bauman LA, et al: Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med 1999; 27:188-195
147. Ignarro LJ, Buga GM, Wood KS, et al: Endothelium- derived relaxing factor produced and reliased from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9269
148. Frostell CG, Blomqvist H, Hedenstierna G, et al: Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 3:427-435
149. Morris GN, Rich GF, Johns RA: Exogenous inhaled nitric oxide as a selective pulmonary vasodilator. Semin Anesthesiol 1996; 15:47-60
150. Abman SH: Inhaled nitric oxide therapy in neonatal and pediatric cardiorespiratory disease. In: Intensive Care in Childhood. Tibboel D, van der Voort E (Eds). Springer Verlag, 1996, 322-336
151. Foubert L, Fleming B, Latimer R: Safety guidelines for use of nitric oxide. Lancet 1992; 339:1615-1616
152. Zapol WM: Minidose inhaled nitric oxide: Less is better. Intensive Care Med 1993; 19:433-434
153. Gerlach H, Rossaint R, Pappert D, et al: Time course and dose response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:449-502
154. Cui L, Okada A: Nitric oxide and manifestations of lesions of skin and gastrointestinal tract in zinc deficiency. Curr Opin Clin Nutr Metab Care 2000; 3:247-252
155. Kinsella JP, Neish SR, Dunbar Ivy D, et al: Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123:103-108
156. Kinsella JP, Dunbar Ivy D, Abman SH: Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 1994; 36:402-408
157. Roberts JD, Polander DM, Lang P: Inhaled NO in PPHN. Lancet 1992; 340:818-819
158. Lonnqvist PA: Inhaled nitric oxide in the management of congenital diaphragmatic hernia. Paediatr Anaesth 1993; 3:388-389
159. Bigatello LM, Hurford WE, Kacmarek RM, et al: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 1994; 80:761-770
160. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
161. Day RW, Hawkins JA, McGough EC, et al: Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000; 69: 1907-1912
162. Roberts JD Jr, Lang P, Bigatello LM: Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-453
163. Haydar A, Mahlere T, Mauriat P: Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340:1545
164. Barrington KJ, Finer NN: Inhaled nitric oxide for respiratory failure in preterm infants (Cochrane Review). Cochrane Database Syst Rev 2001; 4:CD000509
165. Payen DM: Inhaled nitric oxide and acute lung injury. Clin Chest Med 2000; 21: 519-529
166. Clark LC, Gollan F: Survival of mammals breathing organic liquids equilibrated with oxygen at atmosphere pressure. Science 1966; 152:1755-1756
167. Modell JH, Tham MK, Calderwood HW, et al: Distribution and retention of fluorocarbon in mice and dogs after injection or liquid ventilation. Toxicol Appl Pharmacol 1973; 26:86-92
168. Shaffer TH: A brief review: Liquid ventilation. Undersea Biom Res 1987; 14:169-179
169. Shaffer TH, Lowe CA, Bhutani VK, et al: Liquid ventilation: Effects on pulmonary function in meconium stained lambs. Pediatr Res 1983; 19:49-53
170. Shaffer TH, Douglas PR, Lowe CA, et al: Liquid ventilation: Improved gas exchange and lung compliance in preterm lambs. Pediatr Res 1983; 17:303-306
171. Shaffer TH, Wolfson MR, Clark LC: Liquid ventilation. Pediatr Pulmonol 1992; 14: 102-109
172. Fuhrman BP, Paczan PR, De Franciscis M: Perfluorocarbon-associated gas-exchange. Crit Care Med 1991; 19:712-722
173. Lachmann B, Tutuncu AS, Bos JA, et al: Intratracheal Perfluoroocytylbromide (PFOB) in Combination with Mechanical Ventilation. Willemstand, Curacao, International Society for Oxygen Transport to Tissues, 1991
174. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996; 335: 761-767
175. Alliance Pharmaceutical Corp Announces Preliminary Results of LiquiVent Phase 2-3 Clinical Study. May 21, 2001. http:// www.allp.com/press/press.exe? @B0521
176. Foust III R, Tran NN, Cox C, et al: Liquid assisted ventilation: An alternative strategy for acute meconium aspiration injury. Pediatr Pulmonol 1996; 21:316-322
177. Marraro G, Bonati M, Ferrari A, et al: Perfluorocarbon broncho-alveolar lavage and liquid ventilation versus saline bronchoalveolar lavage in adult guinea pig experimental model of meconium inhalation. Intensive Care Med 1998; 24:501-508
178. Richmond PS, Wolfson MR, Shaffer TH: Lung lavage with oxygenated fluorocarbon improves gas exchange and lung compliance in cats with acute lung injury. Crit Care Med 1993; 21:768-774
179. Stern RG, Wolfson MR, McGuckin JF, et al: High resolution computed tomographic bronchiolography using perfluorooctylbromide (PFOB): An experimental model. J Thoracic Imag 1993; 8:300-304
180. Wolfson MR, Greenspan JS, Shaffer TH: Pulmonary administration of vasoactive substances by perfluorochemical liquid ventilation in neonatal lambs. Pediatrics 1996; 97:449-455
181. Zelinka MA, Wolfson MR, Calligaro I, et al: A comparison of intratracheal and intravenous administration of gentamicin during liquid ventilation. Eur J Pediatr 1997; 156: 401-404
182. Cullen AB, Cox CA, Hipp SJ, et al: Intratracheal delivery strategy of gentamicin with partial liquid ventilation. Respir Med 1999; 93:770-778
183. Franz AR, Rohlke W, Franke RP, et al: Pulmonary administration of perfluorodecaline- gentamicin and perfluorodecalinevancomycin emulsions. Am J Respir Crit Care Med 2001; 164:1595-1600
184. Kimless-Gaber DB, Wolfson MR, Shaffer TH: Halothane administration during liquid ventilation. Respir Med 1997; 91:255-262